Integrated bio-physical solution for tr4 & soil-borne disease control

It specifically disrupts the Fusarium oxysporum f. sp. cubense (TR4) cell wall while restoring soil micro-ecological balance. Metrics & Validation Results: Validated by a 70-acre field trial (11,700 trees) in Wufeng Village, Guangzhou. Following TR4 detection in 2025, our intervention halted the outbreak. As of April 2026, the plantation recorded ZERO (0) new infections, demonstrating a 100% protection rate in a high-risk commercial environment. Lab proxies (published in Plants, 2025) further support the antimicrobial efficacy. Competitive Advantages:

Bio-Physical Synergy: ELPC provides physical induction that stabilizes and enhances microbial activity, ensuring consistent efficacy in unstable soil conditions where traditional biocontrols often fail. Dual Action: Simultaneously treats the soil microbiome and strengthens host immunity, creating a comprehensive barrier against colonization. ESG Compliance: 100% non-chemical and non-toxic. The "hang-and-use" design ensures zero residue, ideal for export-grade production. Next Steps & IP Status: Trial evaluation finalizes in late May 2026. We hold a pending Australian patent (No. 2025271030 & No. 2025279780). We seek strategic partners to scale this platform for global TR4 management.